Principaux concurrents
Rendement du dividende (N) Rendement du dividende (N+1) PER (N) Price to Book (N) VE / CA (N) VE / EBITDA (N) VE / EBIT (N) Capi.($)
- - - - - - - 653 k
0,82%0,91%35.47x5x6.71x23.18x28.02x 48,52 Md
1,32%1,41%18.22x1.77x2.05x9.67x12.6x 35,68 Md
0,85%0,96%27.65x3.09x3.42x17.51x22.2x 12,09 Md
0,59%0,6%26.87x3.69x3.96x16.13x22.09x 11,77 Md
3,43%3,78%19.4x3.31x3.39x12.19x14.48x 9,19 Md
3,22%3,19%16.25x1.29x2.09x7.04x9.64x 7,06 Md
5,16%5,52%8.4x1.45x1.97x5.17x6.27x 7,01 Md
0,23%0,23%34.99x6.19x3.99x16.99x18.76x 6,77 Md
0,97%1,17%40.65x9.35x7.79x28.88x32.24x 4,43 Md
1,27%1,73%15.41x0.74x2.09x9.04x11.49x 4,07 Md
3,06%4,01%16.59x2.66x2.64x12.34x11.96x 4,11 Md
2,87%2,95%13.81x2.79x3.21x11.97x13.23x 2,75 Md
3,09%3,43%19.49x5.22x6.08x17.28x18.69x 2,7 Md
Moyenne 2,07% 2,3% 22,56x 3,58x 3,80x 14,41x 17,05x 11,15 Md
Moyenne pondérée par Capi. 1,5% 1,65% 25,69x 3,56x 4,18x 15,88x 19,44x
Pharmacies génériques